Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 51)
23 October 2025
Evonik Launches Noblyst® F Catalysts for Flow Applications
Noblyst® F catalysts, based on carbon granules, offer two particle sizes for flow applications. Evonik explores more options to support continuous processing in pharma and fine chemicals.
23 October 2025
Merck's KEYTRUDA and KEYTRUDA QLEX Get FDA Priority Review for Bladder Cancer Treatment
FDA grants priority review for KEYTRUDA combinations with Padcev, showing improved survival in muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy.
23 October 2025
Cytiva Launches Renewable Polyolefins
Cytiva adopts renewable polypropylene to cut Scope 3 emissions, ensuring high performance in healthcare applications with ISCC PLUS-certified materials.
23 October 2025
NEXTCHEM Secures Engineering Contract with newcleo for Modular Nuclear Plant Design
NEXT-N to design a nuclear plant's conventional island, leveraging MAIRE's expertise, aiming for carbon-neutral chemistry with hydrogen and ammonia integration.
23 October 2025
Asahi Kasei Expands Electrolysis Component Production for Clean Hydrogen
New facilities at Kawasaki Works will boost production of electrolysis components, supporting clean hydrogen and chlor-alkali markets, backed by Japan's GX Supply Chain Development Program.
22 October 2025
Boehringer Ingelheim's JASCAYD® Approved in China for IPF Treatment
Nerandomilast, approved in China for IPF, showed significant lung function improvement in Phase III trials. It offers favorable tolerability and is also FDA-approved in the U.S.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
22 October 2025
Symrise Invests in Cellibre to Boost Innovation in Taste and Cosmetic Markets
Symrise gains access to Cellibre's fermentation tech for scalable, sustainable ingredient production, enhancing supply chain resilience and aligning with sustainability goals.
22 October 2025
EnviTec Biogas AG Wins 2025 Energy Vision Leadership Award
EnviTec recognized for advancing clean energy and circular economy, with notable projects like Germany's largest bio-LNG plant, Güstrow, highlighting economic and environmental benefits.
21 October 2025
Paques Biomaterials to establish PHA pilot from dairy by‑products at GETEC Park Emmen
In partnership with Looop, pilot will convert dairy by‑products (third validated sidestream after sewage sludge and paper process water) into PHA biomass and polymers, aiming for Q1 2026.
21 October 2025
Rely Joins TNO VoltaChem's Anion Exchange Membrane Electrolyser Program
The program aims to advance AEM electrolysers, focusing on safety, energy management, and cost efficiency, using PGM-free technology for sustainable hydrogen production.
21 October 2025
Takeda Partners with Innovent on Oncology Medicines
Takeda gains rights to two late-stage cancer drugs and an option for an early-stage program, focusing on global development and commercialization outside Greater China.
21 October 2025
Veolia to Operate Chile's First Desalination Plant in Valparaíso
Veolia wins a four-year contract to manage a desalination plant and aqueduct in Chile, focusing on renewable energy and local labor, with potential extensions until 2040.
21 October 2025
BASF and IFF Collaborate on Enzyme and Polymer Innovation
The collaboration aims to develop sustainable enzyme and polymer technologies for cleaning and personal care, enhancing performance and reducing environmental impact.
21 October 2025
Evonik Unveils GMP-Grade EUDRACAP® Colon Capsules at CPHI Frankfurt
EUDRACAP® colon capsules enable precise delivery of sensitive actives to the ileo-colonic region, simplifying drug development and accelerating market entry for innovative therapies.
21 October 2025
Borealis and Promix: Recyclable Packaging for PPWR Compliance
Developed recyclable packaging with Borcycle™ M and Promix Microcell Technology, meeting EU's 2030 PPWR targets for recyclability and recycled content in non-food applications.
20 October 2025
NEXTCHEM to Conduct Feasibility Study for Waste-to-Methanol Project in Norway
The project explores converting waste to low-carbon methanol at Mongstad, aiding compliance with EU regulations for marine and aviation fuels.
20 October 2025
Lummus Technology Secures Consecutive Technology Licensor of the Year Award
Lummus also won Best Refining Technology for CDDMESM. They were finalists in four other categories, highlighting their innovation and leadership in the energy sector.
20 October 2025
Merck Begins $3B Pharmaceutical Facility Construction in Virginia
Merck invests $70B in U.S. manufacturing and R&D, creating 500+ full-time and 8,000 construction jobs in Virginia, enhancing biopharmaceutical innovation and domestic production.
20 October 2025
Johnson & Johnson's INLEXZO™ and Cetrelimab Show Promising Pre-Surgical Results in Bladder Cancer
Phase 2b study shows INLEXZO™ plus cetrelimab achieves significant pathologic response rates in muscle invasive bladder cancer patients ineligible for platinum-based chemotherapy.
20 October 2025
Novo Nordisk to Present Oral Semaglutide and Obesity Data at ObesityWeek 2025
New data on oral semaglutide and CagriSema will be presented, focusing on weight loss efficacy, cardiometabolic health, and women's health in obesity management.
20 October 2025
Croda Reveals New Data on KeraBio K31 Hair Repair Innovation
KeraBio K31 offers potent hair repair at low concentrations, enhancing sustainability. It's 99% natural, vegan, and shortlisted for a Product Innovation Award.
20 October 2025
LYB Invests in R&D to Improve Mechanical Recycling Quality
LYB enhances recycling with advanced sorting, decontamination, and analytics for safer, high-quality recyclates, focusing on different technologies for various plastic waste types.
20 October 2025
WuXi Biologics Receives 2025 Global Customer Value Leadership Award from Frost & Sullivan
Recognized for innovation and operational excellence, the company supports 864 projects, achieving a 98% success rate in manufacturing and passing 44 global regulatory inspections.
20 October 2025
Roche's Tecentriq Enhances Survival in Bladder Cancer with ctDNA-Guided Treatment
Tecentriq reduces death risk by 41% and recurrence by 36% in bladder cancer using ctDNA guidance, sparing low-risk patients from unnecessary treatment.
20 October 2025
Roche's Gazyva Approved by FDA for Lupus Nephritis Treatment
FDA approves Gazyva for lupus nephritis, showing superior results in trials, offering a new treatment option to prevent kidney disease progression.
19 October 2025
NEXTCHEM Conducts Feasibility Study for Waste-to-Methanol Project in Norway
The project explores converting waste to low-carbon methanol at Mongstad, aiming to replace marine fuel and produce Sustainable Aviation Fuel.
19 October 2025
Johnson & Johnson's Subcutaneous Amivantamab Shows 45% Response Rate in Head and Neck Cancer
Subcutaneous amivantamab offers rapid, durable responses in head and neck cancer, with 82% tumor shrinkage and a median response duration of 7.2 months.
19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
18 October 2025
Merck and Eisai: KEYTRUDA and LENVIMA Show 5-Year Survival Benefit in Advanced Endometrial Carcinoma
KEYTRUDA and LENVIMA improve 5-year survival rates in advanced endometrial carcinoma compared to chemotherapy, with consistent results across patient subgroups.
← Previous
Next →
